OCEANSIDE, Calif., April 13, 2017 /PRNewswire/ -- AOTI Inc. announced today that over 1,000,000 individual home treatments have been provided with its revolutionary patented Topical Wound Oxygen (TWO2) therapy.
"This is a momentous milestone for our company and a testament to the clinical efficacy of TWO2 therapy, we are delighted to have helped heal the wounds of so many patients within their homes and look forward to even greater adoption of TWO2 therapy in the future," stated Dr. Mike Griffiths, CEO and President of AOTI.
"We are pleased that healthcare professionals around the world are recognizing more and more the clinical benefits of adding Topical Wound Oxygen (TWO2) therapy to existing wound care best practices, and that by helping completely heal chronic wounds will greatly reduce the total cost of care, but more importantly improve the patient's quality of life," added Dr. Griffiths.
Additionally, AOTI Inc. also announced that its fully owned USA operating subsidiary, Advanced Oxygen Therapy Inc., has been awarded DMEPOS accreditation for Home/Durable Medical Equipment Services by the Accreditation Commission for Health Care (ACHC).
Dr. Griffiths further commented that "we are absolutely delighted to have achieved DMEPOS accreditation for Home/Durable Medical Equipment Services that demonstrates our focus on quality and patient care. DMEPOS accreditation will also allow for our unique Topical Wound Oxygen (TWO2) therapy to be provided to both Medicaid and Medicare patients moving forward."
AOTI Inc. is a leading international company providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is unsurpassed in fully closing Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Oceanside, California USA and Galway, Ireland with offices throughout the globe. For more information, see: www.aotinc.net
Dr. Mike Griffiths
CEO and President
(760) 672 1920
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/1000000-topical-wound-oxygen-therapy-home-treatments-provided-and-dmepos-accreditation-awarded-300439324.html
SOURCE AOTI Inc.